Neuraptive Therapeutics, Inc.

PHILADELPHIA, PA · Founded 2017 · CIK 0001713836 · Medtech · Private

Novel therapeutics and medical devices for peripheral nerve injury repair

neuraptive.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$30M
4 Form D · Oct 2022
48 months since last filing
Contracts
—
No federal contracts on record
Patents
8
2 granted · 6 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$25,000
Private capital raisedForm D · SEC$100,000
Private capital raisedForm D · SEC$10,224,998
Private capital raisedForm D · SEC$19,490,348
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1061Serimmune—$20M
106234 Lives, PBC——
1063AKNA HEALTH LLC——
1064Neuraptive Therapeutics, Inc.—$30M
1065Vivamed, Inc.—$3.1M
1066Intelligent Fingerprinting Ltd—$23M
1067Lumier Corp—$50K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 8 related persons
  • Gino DiSciulloDirector
  • Ivan GergelDirector
  • Randy HubbellDirector
  • David JacksonDirector · Executive Officer
  • Greg ParekhDirector
  • David PierceDirector
  • Robert RadieDirector · Executive Officer
  • Evan TzanisExecutive Officer

Patents

USPTO · 2 granted of 8

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.